Log in to save to my catalogue

Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis

Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1921136300

Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis

About this item

Full title

Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis

Publisher

England: BMJ Publishing Group LTD

Journal title

Sexually transmitted infections, 2018-02, Vol.94 (1), p.14-20

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

BackgroundThere is increasing evidence that azithromycin 1 g is driving the emergence of macrolide resistance in Mycoplasma genitalium worldwide. We undertook a meta-analysis of M. genitalium treatment studies using azithromycin 1 g single dose and azithromycin 500 mg on day 1 then 250 mg daily for 4 days (5-day regimen) to determine rates of treat...

Alternative Titles

Full title

Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1921136300

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1921136300

Other Identifiers

ISSN

1368-4973,1472-3263

E-ISSN

1472-3263

DOI

10.1136/sextrans-2016-053060

How to access this item